BioXcel Therapeutics, Inc. SEC filings BTAIQ

BioXcel Therapeutics, Inc. has 672 filings in SEC EDGAR's recent list, going back to Nov 13, 2017. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (acquisition or sale of assets, officer or director change, bylaw or fiscal year change). The company's fiscal year ends on December 31.

BioXcel Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Acquisition or sale of assets, Officer or director change, Bylaw or fiscal year change
Oct 30, 2026 Oct 26, 2026
8-K Current report
New debt, Listing notice
Sep 1, 2026 Aug 31, 2026
8-K Current report
Material agreement, Bankruptcy
Aug 28, 2026 Aug 27, 2026
8-K Current report
Material agreement
Aug 25, 2026 Aug 24, 2026
8-K Current report
Material agreement
Aug 24, 2026 Aug 21, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Material agreement
Aug 11, 2026 Aug 10, 2026
8-K Current report
Material agreement
Aug 3, 2026 Jul 31, 2026
8-K Current report
Material agreement
Jul 6, 2026 Jul 6, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Unregistered share sale
Apr 17, 2026 Apr 15, 2026
8-K Current report
Other events
Apr 1, 2026 Apr 1, 2026
S-8 Employee stock plan registration Mar 27, 2026 —
10-K Annual report Mar 27, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 27, 2026 Mar 27, 2026
8-K Current report
Material agreement
Mar 11, 2026 Mar 10, 2026
424B5 Prospectus supplement Mar 11, 2026 —
8-K Current report
Other events
Feb 12, 2026 Feb 12, 2026
8-K Current report
Officer or director change
Feb 6, 2026 Feb 4, 2026
8-K Current report
Other events
Jan 20, 2026 Jan 20, 2026
8-K Current report
Other events
Jan 12, 2026 Jan 12, 2026
8-K Current report
Shareholder vote results
Dec 15, 2025 Dec 12, 2025
ARS Annual report to shareholders Nov 12, 2025 Dec 31, 2024
DEF 14A Proxy statement Nov 12, 2025 Dec 12, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
8-K Current report
Other events
Nov 10, 2025 Nov 10, 2025
PRE 14A Preliminary proxy statement Oct 31, 2025 Dec 12, 2025
8-K Current report
Other events
Oct 30, 2025 Oct 30, 2025
8-K Current report
Other events
Oct 14, 2025 Oct 14, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 15, 2025 Sep 15, 2025
8-K Current report
Other events
Sep 10, 2025 Sep 10, 2025
8-K Current report
Other events
Aug 27, 2025 Aug 27, 2025
424B5 Prospectus supplement Aug 18, 2025 —
8-K Current report
Other events
Aug 18, 2025 Aug 18, 2025
8-K Current report
Other events
Aug 18, 2025 Aug 18, 2025
8-K Current report
Other events
Aug 15, 2025 Aug 14, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
8-K Current report
Regulation FD disclosure
Aug 11, 2025 Aug 11, 2025
8-K Current report
Other events
Aug 11, 2025 Aug 11, 2025
8-K Current report
Other events
Aug 6, 2025 Aug 6, 2025
424B5 Prospectus supplement Aug 6, 2025 —
8-K Current report
Other events
Aug 1, 2025 Aug 1, 2025
8-K Current report
Other events
Jul 21, 2025 Jul 21, 2025
8-K Current report
Other events
Jul 15, 2025 Jul 15, 2025
8-K Current report
Other events
May 27, 2025 May 27, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
S-8 Employee stock plan registration Apr 4, 2025 —
8-K Current report
Material agreement
Apr 3, 2025 Apr 3, 2025
424B5 Prospectus supplement Apr 3, 2025 —
10-K Annual report Mar 28, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
8-K Current report
Listing notice
Mar 21, 2025 Mar 20, 2025
8-K Current report
Other events
Mar 21, 2025 Mar 20, 2025
8-K Current report
Material agreement
Mar 4, 2025 Mar 3, 2025
424B5 Prospectus supplement Mar 4, 2025 —
8-K Current report
Other events
Mar 3, 2025 Feb 28, 2025
8-K Current report
Bylaw or fiscal year change
Feb 6, 2025 Feb 6, 2025
8-K Current report
Shareholder vote results
Jan 29, 2025 Jan 28, 2025
EFFECT Filing Jan 17, 2025 —
8-K Current report
Officer or director change
Jan 16, 2025 Jan 15, 2025
CORRESP Letter to the SEC Jan 15, 2025 —
UPLOAD Letter from the SEC Jan 15, 2025 —
S-3 Shelf registration Jan 10, 2025 —
8-K Current report
Officer or director change
Jan 8, 2025 Jan 7, 2025
DEF 14A Proxy statement Dec 30, 2024 Jan 28, 2025
PRE 14A Preliminary proxy statement Dec 18, 2024 Jan 28, 2025
8-K Current report
Material agreement
Nov 25, 2024 Nov 22, 2024
424B5 Prospectus supplement Nov 25, 2024 —
424B5 Prospectus supplement Nov 21, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
Nov 21, 2024 Nov 21, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
8-K Current report
Officer or director change
Oct 9, 2024 Oct 3, 2024
8-K Current report
Listing notice
Sep 20, 2024 Sep 16, 2024
8-K Current report
Exit or restructuring costs, Officer or director change
Sep 19, 2024 Sep 17, 2024
8-K Current report
Other events
Sep 9, 2024 Sep 5, 2024
8-K Current report
Other events
Sep 5, 2024 Sep 5, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Material agreement
Jul 17, 2024 Jul 11, 2024
8-K Current report
Results of operations
Jul 16, 2024 Jul 16, 2024
8-K Current report
Other events
Jun 25, 2024 Jun 25, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 12, 2024 Jun 10, 2024
424B7 Filing Jun 4, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 10, 2024
8-K Current report
Regulation FD disclosure, Other events
Apr 22, 2024 Apr 22, 2024
PRE 14A Preliminary proxy statement Apr 19, 2024 Jun 10, 2024
8-K Current report
Regulation FD disclosure, Other events
Apr 10, 2024 Apr 10, 2024
S-8 Employee stock plan registration Apr 3, 2024 —
8-K Current report
Material agreement
Mar 25, 2024 Mar 25, 2024
424B5 Prospectus supplement Mar 25, 2024 —
10-K Annual report Mar 22, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 12, 2024 Mar 12, 2024
8-K Current report
Regulation FD disclosure
Feb 14, 2024 Feb 14, 2024
8-K Current report
Material agreement
Feb 12, 2024 Feb 12, 2024
424B5 Prospectus supplement Feb 8, 2024 —
8-K Current report
Other events
Feb 8, 2024 Feb 8, 2024
8-K Current report
Other events
Feb 8, 2024 Feb 7, 2024
EFFECT Filing Jan 22, 2024 —
CORRESP Letter to the SEC Jan 19, 2024 —
UPLOAD Letter from the SEC Jan 19, 2024 —
S-3 Shelf registration Jan 12, 2024 —
8-K Current report
Other events
Dec 18, 2023 Dec 18, 2023
8-K Current report
Other events
Dec 12, 2023 Dec 12, 2023
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
Dec 6, 2023 Dec 5, 2023
424B5 Prospectus supplement Nov 14, 2023 —
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
EFFECT Filing Nov 13, 2023 —
CORRESP Letter to the SEC Nov 13, 2023 —
RW WD Filing Nov 13, 2023 —
RW Filing Nov 13, 2023 —
CORRESP Letter to the SEC Nov 9, 2023 —
UPLOAD Letter from the SEC Nov 3, 2023 —
S-3 Shelf registration Nov 2, 2023 —
8-K Current report
Regulation FD disclosure
Oct 10, 2023 Oct 10, 2023
8-K Current report
Regulation FD disclosure
Oct 4, 2023 Oct 4, 2023
8-K Current report
Material agreement, Officer or director change
Sep 25, 2023 Sep 19, 2023
8-K Current report
Other events
Sep 19, 2023 Sep 19, 2023
8-K Current report
Other events
Sep 12, 2023 Sep 12, 2023
8-K Current report
Other events
Sep 7, 2023 Sep 7, 2023
8-K Current report
Other events
Aug 22, 2023 Aug 22, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
8-K Current report
Shareholder vote results
Jun 30, 2023 Jun 26, 2023
8-K Current report
Other events
Jun 29, 2023 Jun 29, 2023
DEF 14A Proxy statement May 17, 2023 Jun 26, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 8, 2023 May 8, 2023
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
8-K Current report
Other events
Apr 20, 2023 Apr 20, 2023
S-8 Employee stock plan registration Mar 17, 2023 —
8-K Current report
Other events
Mar 16, 2023 Mar 16, 2023
10-K Annual report Mar 16, 2023 Dec 31, 2022
8-K Current report
Other events
Mar 15, 2023 Mar 15, 2023
8-K Current report
Other events
Mar 10, 2023 Mar 10, 2023
8-K Current report
Results of operations
Mar 9, 2023 Mar 9, 2023
8-K Current report
Other events
Feb 21, 2023 Feb 21, 2023
8-K Current report
Other events
Feb 13, 2023 Feb 13, 2023
8-K Current report
Other events
Nov 30, 2022 Nov 30, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
8-K Current report
Other events
Sep 12, 2022 Sep 12, 2022
8-K Current report
Officer or director change
Aug 19, 2022 Aug 17, 2022
S-8 Employee stock plan registration Aug 16, 2022 —
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Other events
Jul 21, 2022 Jul 21, 2022
8-K Current report
Other events
Jul 6, 2022 Jul 6, 2022
8-K Current report
Officer or director change
Jul 5, 2022 Jun 30, 2022
EFFECT Filing Jun 16, 2022 —
CORRESP Letter to the SEC Jun 14, 2022 —
UPLOAD Letter from the SEC Jun 2, 2022 —
DEL AM Filing May 31, 2022 —
S-3 Shelf registration May 27, 2022 —
8-K Current report
Shareholder vote results
May 23, 2022 May 19, 2022
10-Q Quarterly report May 9, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 9, 2022 May 9, 2022
8-K Current report
Material agreement, New debt, Unregistered share sale
Apr 19, 2022 Apr 19, 2022
EFFECT Filing Apr 7, 2022 —
8-K Current report
Material agreement, Other events
Apr 7, 2022 Apr 1, 2022
DEFA14A Additional proxy material Apr 5, 2022 —
DEF 14A Proxy statement Apr 5, 2022 May 19, 2022
POS AM Filing Mar 11, 2022 —
10-K Annual report Mar 11, 2022 Dec 31, 2021
POSASR Filing Mar 11, 2022 —
8-K Current report
Results of operations
Mar 10, 2022 Mar 10, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2022 Jan 13, 2022
8-K Current report
Other events
Dec 2, 2021 Dec 1, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
8-K Current report
Regulation FD disclosure
Oct 25, 2021 Oct 25, 2021
8-K Current report
Officer or director change
Oct 13, 2021 Oct 8, 2021
8-K Current report
Regulation FD disclosure
Sep 9, 2021 Sep 9, 2021
10-Q Quarterly report Aug 10, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 10, 2021 Aug 10, 2021
8-K Current report
Officer or director change
Jul 23, 2021 Jul 19, 2021
8-K Current report
Material agreement
Jun 25, 2021 Jun 25, 2021
424B5 Prospectus supplement Jun 24, 2021 —
424B5 Prospectus supplement Jun 22, 2021 —
8-K Current report
Other events
Jun 22, 2021 Jun 22, 2021
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 14, 2021 Jun 11, 2021
8-K Current report
Material agreement
May 10, 2021 May 10, 2021
424B5 Prospectus supplement May 10, 2021 —
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
DEFA14A Additional proxy material Apr 27, 2021 —
DEF 14A Proxy statement Apr 27, 2021 Jun 11, 2021
PRE 14A Preliminary proxy statement Apr 14, 2021 Jun 11, 2021
8-K Current report
Auditor change, Other events
Mar 15, 2021 Mar 15, 2021
10-K Annual report Mar 12, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 11, 2021 Mar 11, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 1, 2021 Feb 23, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BTAIQ (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Haven, CT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1720893

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.